Agno Pharma Acquires Actylis Eugene (Legacy Cascade Chemistry) in Eugene, Oregon

Aceto Acquires Cascade Chemistry

June 2, 2021

Pharmaceuticals

Aceto, a global provider of specialty materials for life sciences and advanced technology end markets, acquired Eugene, Oregon-based Cascade Chemistry, a CDMO specializing in active pharmaceutical ingredients (APIs) and advanced intermediates. The acquisition strengthens Aceto's U.S. cGMP custom manufacturing capabilities and expands North American API manufacturing capacity; Cascade Chemistry recently announced a facility expansion that will triple its clinical-stage API capacity.

New Mountain-backed Actylis Integrates Aceto and 10 Specialty Ingredients Businesses

September 26, 2022

Manufacturing

New Mountain Capital’s new platform Actylis launched by combining Aceto and ten acquired specialty ingredient manufacturers and sourcing firms into a single global company. The combined business unites GMP and non‑GMP manufacturing, R&D, quality and sourcing capabilities across multiple countries to supply critical raw materials for pharmaceuticals, nutrition, cosmetics, agriculture and specialty chemicals.

Aceto Consolidates Acquisition of Six Specialty Manufacturers

January 26, 2022

Pharmaceuticals

Aceto has consolidated and integrated six recent manufacturing-related acquisitions — A&C, A&C Bio Buffer, Cascade Chemistry, Finar, Islechem and Syntor Fine Chemicals — to create a hybrid manufacturing/distribution model that strengthens its GMP manufacturing, R&D and supply-chain capabilities across pharmaceuticals, biopharma, vaccines, nutraceuticals, agri-science and specialty chemicals. The acquisitions expand Aceto’s global manufacturing footprint (North America, Europe and Asia), broaden its portfolio of excipients, APIs and process solutions, and improve supply-chain resilience for customers.

Actylis Acquires Pharm-Rx

October 7, 2024

Pharmaceuticals

Actylis has acquired Pharm-Rx, a Saddle Brook, New Jersey-based supplier of specialty ingredients for the vitamin, mineral and supplement (VMS), OTC and pharmaceutical markets. The deal expands Actylis' nutrition and OTC capabilities and supplier partnerships; Pharm-Rx will continue to operate under its brand and Mark Bostel will become President, Global Nutrition and OTC for Actylis. Financial terms were not disclosed.

Azelis Acquires Azienda Chimica e Farmaceutica (ACEF)

July 9, 2025

Industrial Services

Azelis Group NV has acquired 100% of Azienda Chimica e Farmaceutica (ACEF), a Piacenza-based distributor of specialty raw materials and ingredients for the cosmetic, nutraceutical, galenic and pharmaceutical markets. The acquisition strengthens Azelis's footprint in Italy, expands its product portfolio and technical capabilities, and brings ACEF's laboratories and GMP-compliant facilities into Azelis's network.

Revelation Pharma Acquires Cascade Specialty Pharmacy

January 22, 2025

Healthcare Services

Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Cascade Specialty Pharmacy of Poulsbo, Washington. The acquisition expands Revelation Pharma's ENT and animal-health compounding capabilities and brings Cascade's existing customers and product lines into Revelation's national fulfillment network; Cascade's former owner Brandon Knott will remain involved as an ENT Allergy Product Specialist.